PETULA GUNN: Open Payments
NPI 1659553774 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 29 payments from 13 companies in 2025. Trend: 2023 $634 · 2024 $1,016 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $141 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Lilly USA, LLC | 4 | $68 |
| Novo Nordisk Inc | 3 | $52 |
| Abbott Laboratories | 3 | $49 |
| ABBVIE INC. | 3 | $42 |
| SANOFI PASTEUR INC. | 2 | $41 |
| PFIZER INC. | 2 | $37 |
| Amgen Inc. | 2 | $35 |
| Seqirus USA Inc | 1 | $23 |
Products named: AREXVY, AIRSUPRA, MOUNJARO, FREESTYLE LIBRE 3, FLUZONE HIGH-DOSE, PREVNAR 20, Ozempic, EVENITY.
Industry payments across GA — which companies pay providers there.
